Bimatoprost 0,1 mg/mL en la práctica clínica: Multicenter, prospective, open-label, observational study of Bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension, Pfenningsdorf S. et al., "Clin ophthalmol" 2012; 6:739-746